Welcome to LookChem.com Sign In|Join Free
  • or
1-(2,5-dibromophenyl)ethanol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

32917-51-4

Post Buying Request

32917-51-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

32917-51-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 32917-51-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,9,1 and 7 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 32917-51:
(7*3)+(6*2)+(5*9)+(4*1)+(3*7)+(2*5)+(1*1)=114
114 % 10 = 4
So 32917-51-4 is a valid CAS Registry Number.

32917-51-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2,5-dibromophenyl)ethanol

1.2 Other means of identification

Product number -
Other names 2,5-Dibromphenylmethylcarbinol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:32917-51-4 SDS

32917-51-4Relevant academic research and scientific papers

SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS

-

Page/Page column 73; 74, (2015/03/28)

The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.

Synthesis and characterization of chiral benzylic ether-bridged periodic mesoporous organosilicas

Morell, Juergen,Chatterjee, Sangam,Klar, Peter J.,Mauder, Daniel,Shenderovich, Ilja,Hoffmann, Frank,Froeba, Michael

experimental part, p. 5935 - 5940 (2009/05/31)

The first synthesis of a chiral periodic mesoporous organosilica (PMO) carrying benzylic ether bridging groups is reported. By hydrolysis and condensation of the new designed chiral organosilica precursor 1,4-bis(triethoxysilyl)-2-(1 -methoxyethyl)benzene

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 32917-51-4